ライフサイエンスコーパス: subconjunctival injection

1 er: suprachoroidal > intravitreal >posterior subconjunctival injection.

2 to achieve high intraocular penetration with subconjunctival injection.

3 when compared to intravitreal and posterior subconjunctival injections.

4 Daily subconjunctival injections (0.01-10 pmol/d protein) were

5 Both techniques of MMC delivery (subconjunctival injection and direct scleral application

6 of six New Zealand white rabbits was given a subconjunctival injection at the 12-o'clock position wit

7 ocular antibiotic accumulation with a single subconjunctival injection compared to 3x daily eye drops

8 = 5) 10 weeks of age received two 20-microL subconjunctival injections delivered with a 72-hour inte

9 Subconjunctival injection for each group (XG-102 90 mug,

10 e VEGFR1_MO, STD MO and PBS groups following subconjunctival injection in mice that underwent normal

11 cinolone acetonide, and PBS groups following subconjunctival injection in mice that underwent penetra

12 40 mug) was administered every 3 months as a subconjunctival injection in only one randomly assigned

13 rance of the nanoparticles in the eyes after subconjunctival injection in vivo.

14 Anterior subconjunctival injection led to high, though short-live

15 Subconjunctival injection may be a useful approach for d

16 -inflammatory drug (NSAID) or intraoperative subconjunctival injection of 2 mg triamcinolone acetonid

17 The time course and extent of mydriasis from subconjunctival injection of 2% pirenzepine were determi

18 After general anesthesia rabbits received a subconjunctival injection of 2.5 mg in 0.5 ml, 5 mg in 1

19 Patients were administered a single subconjunctival injection of 250 muL XG-102 90 mug (n =

20 The study drug was administered as a single subconjunctival injection of 30 muL (1320 mug) sirolimus

21 eedling with HA-5FU mixture or needling with subconjunctival injection of 5FU solution alone.

22 The right eye of 15 mice received a single subconjunctival injection of a 1.5-microL solution of 0.

23 ch case, patients were administered a 0.5 cc subconjunctival injection of a 1:1 Cefazolin (50 mg/cc):

24 Finally, we demonstrate that a subconjunctival injection of a Gal-8 inhibitor markedly

25 ed keratitis was significantly reduced after subconjunctival injection of a monoclonal antibody (mAb)

26 Intra-Tenon or subconjunctival injection of a solution of mitomycin C (

27 nase modulation after AA treatment, a single subconjunctival injection of AA (300 microg) was deliver

28 Conversely, subconjunctival injection of Ab to ICAM-1 did not impair

29 Subconjunctival injection of Ab to PECAM-1 significantly

30 ek-old, LH(BETA)T(AG) mice received a single subconjunctival injection of anecortave acetate (1200, 6

31 ek-old, LH(BETA)T(AG) mice received a single subconjunctival injection of anecortave acetate (600, 30

32 The fellow eye was given a subconjunctival injection of balanced salt solution.

33 ning suturing after receiving a preoperative subconjunctival injection of bevacizumab in his right ey

34 Postoperative subconjunctival injection of bevacizumab is associated w

35 Subconjunctival injection of cetuximab with the administ

36 Depletion of local macrophages, through subconjunctival injection of clodronate liposome, attenu

37 We induced mast cell degranulation by local subconjunctival injection of compound 48/80.

38 Subconjunctival injection of disodium cromoglycate signi

39 Subconjunctival injection of DSP-NP is a promising appro

40 16-week-old mice were treated with a single subconjunctival injection of either anecortave acetate (

41 Subconjunctival injection of HA-5FU to revive bleb funct

42 help prove the concept that subcutaneous and subconjunctival injection of HC-HA/PTX3 is a novel appro

43 Anterior subconjunctival injection of ketorolac produced high int

44 s showed that different suturing techniques, subconjunctival injection of long-acting steroid, and ta

45 these adverse effects just few minutes after subconjunctival injection of mepivacaine 2% solution (Sc

46 CpG DNA, which binds TLR9, was tested after subconjunctival injection of mice with control or CpG DN

47 After subconjunctival injection of mitomycin C (MMC), a novel

48 Subconjunctival injection of mitomycin C in the rabbit p

49 Subconjunctival injection of MMP13i prior to P. aerugino

50 Strikingly, subconjunctival injection of P-IQACRG was very effective

51 ncluded topical PA with or without NSAID and subconjunctival injection of TA (Kenalog; Bristol-Myers-

52 In the mouse cornea, subconjunctival injection of the morpholino-inhibited co

53 Dutch-belted rabbits received a subconjunctival injection of triamcinolone acetonide to

54 A single subconjunctival injection of XG-102 at the end of ocular

55 Subconjunctival injections of 0.0002% to 0.2% pirenzepin

56 Subconjunctival injections of 0.002% or less pirenzepine

57 Subconjunctival injections of 0.02% or greater pirenzepi

58 or patients allergic to penicillin, separate subconjunctival injections of 0.25 cc each of Vancomycin

59 d to receive a postoperative course of seven subconjunctival injections of bevacizumab (1.25 mg, 25 m

60 d to receive a postoperative course of seven subconjunctival injections of CAT-152 (1 mg/mL), 5-FU (5

61 ce was tested by depleting macrophages using subconjunctival injections of clodronate-containing lipo

62 Control mice received two subconjunctival injections of DMSO or of saline solution

63 concentration of 0.2 mg/mL or postoperative subconjunctival injections of either ilomastat or phosph

64 randomly allocated to receive postoperative subconjunctival injections of either phosphate-buffered

65 group of mice of both strains also received subconjunctival injections of exogenous IFN-gamma or veh

66 BETA)T(AG) mice were treated with six serial subconjunctival injections of focally delivered carbopla

67 g, 16-week-old mice were treated with single subconjunctival injections of the selective vascular-tar

68 Cs were selectively depleted by timed local (subconjunctival) injection of diphtheria toxin (DT) into

69 randomized to MMC delivered by preoperative subconjunctival injection or by intraoperative direct sc

70 venous delivery than after focal delivery by subconjunctival injection or CCI.

71 oroid, vitreous humor, and optic nerve after subconjunctival injection or iontophoretic carboplatin d

72 ix cycles of 5.0 mg carboplatin delivered by subconjunctival injection or six transscleral carboplati

73 caine group experienced more pain during the subconjunctival injection (p = 0.001) and a significant

74 Ketorolac was administered by anterior subconjunctival injection, posterior periocular injectio

75 to prevent corneal graft rejection following subconjunctival injection provided initially during tran

76 It was reported that, after subconjunctival injection, RNA nanoparticles with tri-wa

77 ocal recombinant Gal-1 (rGal-1) treatment by subconjunctival injections significantly diminishes P. a

78 red to the mouse retina and uveal tissues by subconjunctival injection through transscleral diffusion

79 arboplatin was administered through biweekly subconjunctival injections to right eyes only for 3 week

80 either mBD1 or mBD2 small interfering RNA by subconjunctival injection together with topical applicat

81 ic preoperative antibiotics or postoperative subconjunctival injection was associated with a 40% to 5

82 lated-P-IQACRG delivered via intravitreal or subconjunctival injection was demonstrated by avidin-bio

83 on (Control group) or topical anesthesia and subconjunctival injection with 2% lidocaine (Lidocaine g

84 on of neutrophil recruitment was achieved by subconjunctival injection with an antibody against macro

85 Infected BALB/c mice also were tested after subconjunctival injection with recombinant murine (rm)ST

86 with HSV-1 were vaccinated periocularly (by subconjunctival injection) with gD1 and adjuvant, gD2 an